1. Home
  2. UCAR vs PTHL Comparison

UCAR vs PTHL Comparison

Compare UCAR & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U Power Limited

UCAR

U Power Limited

N/A

Current Price

$1.85

Market Cap

9.2M

ML Signal

N/A

PTHL

Pheton Holdings Ltd Class A Ordinary Shares

HOLD

Current Price

$0.58

Market Cap

8.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCAR
PTHL
Founded
2013
1998
Country
China
China
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
8.8M
IPO Year
2023
2024

Fundamental Metrics

Financial Performance
Metric
UCAR
PTHL
Price
$1.85
$0.58
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
32.6K
76.8K
Earning Date
10-13-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,816,075.00
$448,196.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
57.22
N/A
52 Week Low
$1.74
$0.47
52 Week High
$9.43
$32.00

Technical Indicators

Market Signals
Indicator
UCAR
PTHL
Relative Strength Index (RSI) 32.67 41.04
Support Level $1.77 $0.59
Resistance Level $1.95 $0.63
Average True Range (ATR) 0.13 0.05
MACD -0.02 0.01
Stochastic Oscillator 7.55 36.70

Price Performance

Historical Comparison
UCAR
PTHL

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Share on Social Networks: